Search clinical trials for: dalotuzumab
Total 94 results
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid Tumors
-
Merck Sharp & Dohme LLCAriad PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCCompletedMultiple Myeloma | Solid Tumor
-
Merck Sharp & Dohme LLCCompleted
-
Seagen Inc.Genentech, Inc.CompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States
-
Bristol-Myers SquibbAbbVieCompletedSmoldering Multiple MyelomaUnited States
-
AbbottBristol-Myers SquibbTerminated
-
Merck Sharp & Dohme LLCTerminated
-
Bristol-Myers SquibbCompleted
-
Seagen Inc.Genentech, Inc.Completed
-
Seagen Inc.Genentech, Inc.CompletedLeukemia, Lymphocytic, ChronicUnited States
-
Seagen Inc.Genentech, Inc.CompletedMultiple MyelomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Facet BiotechCompletedMultiple MyelomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Bristol-Myers SquibbCompleted
-
University of Wisconsin, MadisonRadius Health, Inc.Active, not recruitingOsteoporosis | Arthroplasties, Knee ReplacementUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Radius Health, Inc.Completed
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Wake Forest University Health SciencesBristol-Myers Squibb; Atrium Health Levine Cancer InstituteActive, not recruitingMultiple MyelomaUnited States
-
Bristol-Myers SquibbNo longer availableMultiple Myeloma
-
Anklam ExtraktBioTeSys GmbHCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Tulane University School of MedicineKaryopharm Therapeutics IncWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
Seagen Inc.Genentech, Inc.CompletedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States
-
Assistance Publique - Hôpitaux de ParisWithdrawn
-
M.D. Anderson Cancer CenterRecruitingPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Myelofibrosis Transformation in Essential ThrombocythemiaUnited States
-
SCRI Development Innovations, LLCBristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Natalie CallendarBristol-Myers SquibbWithdrawn
-
Seagen Inc.Genentech, Inc.CompletedMultiple MyelomaUnited States
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaTaiwan
-
Bristol-Myers SquibbAbbVieCompleted
-
University of Heidelberg Medical CenterCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Withdrawn
-
Sundar JagannathBristol-Myers SquibbNo longer available
-
Bristol-Myers SquibbNo longer available
-
Merck Sharp & Dohme LLCCompleted
-
Seagen Inc.Genentech, Inc.TerminatedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States, France, Spain, Belgium, Australia, Germany, Poland, Italy, Czech Republic, Hungary
-
Raija SilvennoinenBristol-Myers Squibb; Amgen; Hospital District of Helsinki and UusimaaCompletedMultiple Myeloma in RelapseFinland, Sweden
-
AbbVie (prior sponsor, Abbott)Bristol-Myers SquibbCompleted
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Rho Federal Systems Division, Inc.; Autoimmunity Centers...TerminatedIgG4 Related Disease | IgG4-RDUnited States
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates
-
Bristol-Myers SquibbAbbVieCompleted
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom